4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-25-000089
CIK 0000875320other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:31 PM ET
Size
4.5 KB
Accession
0000875320-25-000089
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Tax Payment
Common Stock
2025-02-14$463.46/sh−6,553$3,037,053→ 129,380 total
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:31 PM ET
- Size
- 4.5 KB